Action Decision Diagnostics (CE) - DECN

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,000001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,0001

Clôture Veille

0,000001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

57 890

Volume financier

VWAP

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

July 6, 2020 -- Investorshub NewsWire -- via Microcap Daily -- BY JACOB WATSON -- Alternet Systems, Inc. (OTCMKTS: ALYI...

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology GenViroTM Ant...

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN SETS PLAN TO MAKE UPCOMING PATENT INFRINGEMENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOVERY...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN NEXT 7 DAYS, CLINICAL TRIALS TESTING TO BEGIN IN...

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE GOVERNMENT...

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

++ COMPANY HAS ALSO AGREED TO MANUFACTURE A HOUSE BRAND PRODUCT FOR A “BIG BOX” AND WILL PROVIDE A FORECAST AND PRICE...

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court) ...

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

++ COMPANY ALSO READIES IMMINENT APPEAL IN THE JOHNSON & JOHNSON PATENT INFRINGEMENT MATTER WITH THE U.S. COURT OF APPEALS FOR THE FEDERAL...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATIONS ++ IP...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

++ DECN TO LAUNCH GENCHOICE! PRODUCT IN SELECT INTERNATIONAL MARKETS JANUARY 2, 2019 AND TO FILE FOR CE MARK IN THE EU AND HEALTH CANADA APPROVAL...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	1.0E-6	1.0E-6	1.0E-6	4741	1.0E-6	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	49054	1.0E-6	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	57890	1.0E-6	CS
26	0	0	1.0E-6	0.0001	1.0E-6	133346	3.235E-5	CS
52	0	0	1.0E-6	0.0001	1.0E-6	114808	2.397E-5	CS
156	-0.001199	-99.9166666667	0.0012	0.0014	1.0E-6	96587	0.00010494	CS
260	-0.279849	-99.9996426657	0.27985	0.497	1.0E-6	1229552	0.18070499	CS

DECN - Frequently Asked Questions (FAQ)

What is the current Decision Diagnostics (CE) share price?

The current share price of Decision Diagnostics (CE) is US$ 0,000001

What is the 1 year trading range for Decision Diagnostics (CE) share price?

Decision Diagnostics (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,16 (79 900,00%)	278
ELIQQElectriq Power Holdings Inc (CE)	US$ 0,02 (19 900,00%)	106
YVRLFLiquid Media Group Ltd (CE)	US$ 0,0001 (9 900,00%)	629
CENBFCEN Biotech Inc (CE)	US$ 0,0001 (9 900,00%)	2,52k
NSPTNewron Sport (PK)	US$ 0,0001 (9 900,00%)	20k
AILEQiLearningEngines Inc (CE)	US$ 0,000001 (-100,00%)	111,69k
TRCNFTransnational Cannabis Ltd (CE)	US$ 0,000001 (-99,90%)	1,5k
HGYNHong Yuan Holding Group (PK)	US$ 0,0001 (-99,60%)	5,36k
MCRTMicroart Inc (CE)	US$ 0,000001 (-99,50%)	590
ZAZAZaZa Energy Corporation (CE)	US$ 0,000001 (-99,00%)	1,62k
TMSHTransGlobal Assets Inc (PK)	US$ 0,0003 (-25,00%)	363,17M
KGKGKona Gold Beverage Inc (PK)	US$ 0,0001 (0,00%)	329,68M
DPLSDarkPulse Inc (PK)	US$ 0,00035 (-30,00%)	277,51M
VGTLVGTel Inc (PK)	US$ 0,002 (100,00%)	249,77M
EMEDElectroMedical Technologies Inc (PK)	US$ 0,0002 (-33,33%)	248,47M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Decision Diagnostics Corporation (CE) (DECN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

DECN Dernières nouvelles

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

DECN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Decision Diagnostics Corporation (CE) (DECN) Cours

Decision Diagnostics Corporation (CE) (DECN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

DECN Dernières nouvelles

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

DECN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités